4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide

References

• Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
  • J. R. Somoza, R. J. Skene, B. A. Katz, C. Mol, J. D. Ho, A. J. Jennings, C. Luong, A. Arvai, J. J. Buggy, E. Chi, J. Tang, B.-C. Sang, E. Verner, R. Wynands, E. M. Leahy, D. R. Dougan, G. Snell, M. Navre, M. W. Knuth, R. V. Swanson, D. E. McRee, L. W. Tari, Structure 2004, 12, 1325.
• Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase and Inducers of Terminal Cell Differentiation
  • M. Jung, G. Brosch, D. Kölle, H. Scherf, C. Gerhäuser, P. Loidl, J. Med. Chem. 1999, 42, 4669.
• The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN₂ RNA/protein levels in spinal muscular atrophy cells
  • M. Riessland, L. Brichta, E. Hahnen, B. Wirth, Hum. Genet. 2006, 120, 101.
• M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells
  • N. Takai, T. Ueda, M. Nishida, K. Nasu, H. Narahara, Gynecol. Oncol. 2006, 101, 108.
• Histone deacetylase inhibitor M344 inhibits cell proliferation and induces apoptosis in human THP-1 leukemia cells
  • X. Li, B. D. Chen, Am. J. Biomed. Sci. 2009, 1, 352.
• Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB
  • H. Ying, Y. Zhang, X. Zhou, X. Qu, P. Wang, S. Liu, D. Lu, H. Zhu, PLoS One 2012, 7, e48832.